Spiolto

tiotropium/olodaterol

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Spiolto, covering 2022-10-27 to 2022-10-27. Get the full timeline:

Most recent: Clinical Trial Update: Cardiac Effects of Spiolto®/Respimat® in Patients With Congestive Heart Failure and COPD [Phase 4]